Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Some dibenzo compounds might help treat cancer with fewer side effects.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Finasteride helps reduce pain and inflammation in animals.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.